このエピソードについて
Black women have a higher risk of developing triple-negative breast cancer at a young age than white women. At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Holly Pederson, of the Cleveland Clinic, and Dr. Elisha Hughes, of Myriad Genetics, presented their research on how a polygenic risk score can help predict the risk of early-onset triple-negative breast cancer in Black women.
Listen to the episode to hear Drs. Pederson and Hughes explain:
what a polygenic risk score is
the results of their research
how the results are being used
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
このポッドキャストの他のエピソード
Oligometastatic breast cancer is breast cancer that’s spread to parts of the body away from the breast, like the bones or liver, but there are only a few small cancer lesions at the metastatic site. Dr. Jennifer Plichta, of Duke University, was the corresponding author of a paper looking at treatme…
At the Living Beyond Breast Cancer 2026 Conference on Metastatic Breast Cancer, five members of the Breastcancer.org metastatic virtual support groups shared what they’d tell someone who’s just been diagnosed with metastatic breast cancer. They talked to us about the importance of having hope allow…
Felicia Marie Knaul, PhD, is a global health researcher whose work focuses on strengthening health systems, advancing gender equity, and improving access to care for those who need it most. She’s also lived through a breast cancer diagnosis and treatment, and that experience informs her efforts to …
Eleonora Teplinsky, MD, is the head of breast and gynecologic medical oncology and Valley-Mount Sinai Comprehensive Cancer Center in Paramus, New Jersey, as well as an ASCO breast cancer expert. She explained the most compelling research results on breast cancer presented at the 2026 American Socie…
At the 2026 American Society of Clinical Oncology Annual Meeting poster session, we asked four scientists to discuss their research.
Listen to the episode to hear:
Peter Stanfield, of the University of Wisconsin, explains his research on cancer screening rates in transgender and gender-divers…
免責: このページに埋め込まれているポッドキャストとアートワークは Breastcancer.org からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
